Michal Kaleta

University Hospital Olomouc

Czech Republic

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (5)

Dorota Šebelová

Lékařská Fakulta Univerzita Palackého v Olomouci

CZECH REPUBLIC

View details

Miroslav Strnad

CZECH REPUBLIC

View details

David Friedecký

CZECH REPUBLIC

View details

Jana Oklestkova

Assistant professor

CZECH REPUBLIC

View details

Ondřej Novák

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michal Kaleta

Research Interests

Contact this professor

Articles (10)

Metabolomics: Potential non-protein biomarker candidates of Parkinson's disease

RT-QuIC: a highly promising diagnostic method for neurodegenerative diseases—advantages and limitations

Targeted analysis of seven selected tryptophan-melatonin metabolites: Simultaneous quantification of plasma analytes using fast and sensitive UHPLC–MS/MS

Patients with Neurodegenerative Proteinopathies Exhibit Altered Tryptophan Metabolism in the Serum and Cerebrospinal Fluid

Simultaneous Determination of Selected Steroids with Neuroactive Effects in Human Serum by Ultrahigh-Performance Liquid Chromatography–Tandem Mass Spectrometry

Proceedings of the 4th CNPD Conference

Cerebrospinal fluid and blood serum biomarkers in neurodegenerative proteinopathies: A prospective, open, cross-correlation study

Quantitative Determination of Endogenous Tetrahydroisoquinolines, Potential Parkinson’s Disease Biomarkers, in Mammals

Quantitative Determination of Endogenous Tetrahydroisoquinolines, Potential Parkinson's Disease Biomarkers, in Mammals

Analytical Methods for the Determination of Neuroactive Steroids

Collaborators (5)

Dorota Šebelová

Miroslav Strnad

David Friedecký

Jana Oklestkova

Ondřej Novák

Make your next move.